PEPG - PepGen Inc. Stock Price, Fair Value and News
14.17USD-0.32Â (-2.21%)Market Closed
Market Summary
USD14.17-0.32
Market Closed-2.21%
PEPG Alerts
PEPG Stock Price
View Fullscreen
PEPG RSI Chart
PEPG Valuation
PEPG Price/Earnings (Trailing)
PEPG Profitability
PEPG Fundamentals
PEPG Earnings
Breaking Down PEPG Revenue
Last 7 days
23.8%
Last 30 days
11.0%
Last 90 days
24.3%
Trailing 12 Months
-2.0%
How does PEPG drawdown profile look like?
PEPG Financial Health
PEPG Investor Care
Tracking the Latest Insider Buys and Sells of PepGen Inc.
Filter Transactions| Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
|---|---|---|---|---|---|---|
| Feb 09, 2024 | ra capital management, l.p. | bought | 27,212,800 | 10.64 | 2,557,590 | - |
| Nov 30, 2023 | mcarthur james g | bought | 7,055 | 4.165 | 1,694 | president and ceo |
| Jun 08, 2023 | mcarthur james g | acquired | 6,452 | 2.71 | 2,381 | president and ceo |
| Jun 08, 2023 | mcarthur james g | sold | -38,187 | 16.0386 | -2,381 | president and ceo |
| Jun 07, 2023 | mcarthur james g | sold | -136,618 | 16.2273 | -8,419 | president and ceo |
| Jun 07, 2023 | mcarthur james g | acquired | 22,815 | 2.71 | 8,419 | president and ceo |
| Jun 06, 2023 | mcarthur james g | acquired | 49,186 | 2.71 | 18,150 | president and ceo |
| Jun 06, 2023 | mcarthur james g | sold | -293,660 | 16.1796 | -18,150 | president and ceo |
| Jun 05, 2023 | mcarthur james g | acquired | 1,355 | 2.71 | 500 | president and ceo |
| Jun 05, 2023 | mcarthur james g | sold | -8,028 | 16.056 | -500 | president and ceo |
Which funds bought or sold PEPG recently?
View All Details| Datesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
|---|---|---|---|---|---|---|
| May 02, 2024 | NISA INVESTMENT ADVISORS, LLC | new | - | 132 | 132 | -% |
| May 01, 2024 | CONCOURSE FINANCIAL GROUP SECURITIES, INC. | sold off | - | - | - | -% |
| Apr 30, 2024 | Avior Wealth Management, LLC | new | - | 29.00 | 29.00 | -% |
| Apr 25, 2024 | Bank of New York Mellon Corp | reduced | -2.09 | 238,530 | 452,172 | -% |
| Apr 25, 2024 | Zurcher Kantonalbank (Zurich Cantonalbank) | unchanged | - | 8.00 | 15.00 | -% |
| Apr 23, 2024 | AMALGAMATED BANK | reduced | -72.22 | -3,000 | 5,000 | -% |
| Apr 05, 2024 | CWM, LLC | new | - | - | - | -% |
| Mar 11, 2024 | VANGUARD GROUP INC | added | 0.67 | 887,829 | 3,442,020 | -% |
| Mar 01, 2024 | GOLDMAN SACHS GROUP INC | new | - | 192,522 | 192,522 | -% |
| Feb 28, 2024 | AMERICAN INTERNATIONAL GROUP, INC. | reduced | -0.4 | 8,492 | 33,973 | -% |
Are Funds Buying or Selling PEPG?
Calls
Puts
Net Call Options
No. of Funds
PEPG Alerts
Unveiling PepGen Inc.'s Major ShareHolders
| Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
|---|---|---|---|---|---|
| Apr 09, 2024 | oxford science enterprises plc | 14.70% | 0 | SC 13G | |
| Mar 11, 2024 | ra capital management, l.p. | 33.1% | 10,695,135 | SC 13D/A | |
| Feb 14, 2024 | viking global investors lp | 6.2% | 1,482,434 | SC 13G/A | |
| Feb 13, 2024 | ra capital management, l.p. | 34.1% | 10,695,135 | SC 13D/A | |
| Dec 11, 2023 | fmr llc | - | 0 | SC 13G/A | |
| Feb 14, 2023 | viking global investors lp | 6.5% | 1,544,631 | SC 13G/A | |
| Feb 10, 2023 | fmr llc | - | 0 | SC 13G/A | |
| Feb 09, 2023 | fmr llc | - | 0 | SC 13G | |
| Jan 17, 2023 | qatar investment authority | 5.26% | 1,243,951 | SC 13G/A |
Recent SEC filings of PepGen Inc.
View All Filings| Date Filed | Form Type | Document | |
|---|---|---|---|
| May 01, 2024 | DEFA14A | DEFA14A | |
| Apr 26, 2024 | ARS | ARS | |
| Apr 26, 2024 | DEF 14A | DEF 14A | |
| Apr 16, 2024 | PRE 14A | PRE 14A | |
| Apr 09, 2024 | 4/A | Insider Trading | |
| Apr 09, 2024 | SC 13G | Major Ownership Report | |
| Mar 29, 2024 | 10-K/A | Annual Report | |
| Mar 15, 2024 | 8-K | Current Report | |
| Mar 13, 2024 | 8-K | Current Report | |
| Mar 12, 2024 | 144 | Notice of Insider Sale Intent |
PepGen Inc. News
Latest updates
PepGen Inc. Earnings Report: Key Takeaways & Analysis
Balance Sheet
(In Millions)
| Balance Sheet | (In Millions) | |||||||||
| Description | (%) Q/Q | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 |
| Assets | -12.9% | 143 | 164 | 182 | 201 | 217 | 208 | 231 | 132 | 144 |
| Current Assets | -15.3% | 113 | 133 | 150 | 168 | 186 | 204 | 226 | 126 | 140 |
| Cash Equivalents | -37.6% | 81.00 | 130 | 147 | 165 | 182 | 196 | 219 | 119 | 133 |
| Net PPE | -5.5% | 5.00 | 5.00 | 5.00 | 5.00 | 3.00 | 3.00 | 3.00 | 3.00 | 1.00 |
| Liabilities | -9.8% | 35.00 | 38.00 | 35.00 | 36.00 | 38.00 | 16.00 | 21.00 | 16.00 | 11.00 |
| Current Liabilities | -16.3% | 18.00 | 21.00 | 17.00 | 18.00 | 19.00 | 16.00 | 21.00 | 16.00 | 10.00 |
| Shareholder's Equity | -13.9% | 108 | 126 | 147 | 165 | 180 | 193 | 210 | - | -32.08 |
| Retained Earnings | -12.0% | -181 | -161 | -138 | -119 | -102 | -87.90 | -69.30 | -52.00 | -33.75 |
| Additional Paid-In Capital | 0.7% | 290 | 288 | 286 | 284 | 283 | 281 | 280 | 2.00 | 2.00 |
| Shares Outstanding | 0.1% | 24.00 | 24.00 | 24.00 | 24.00 | 24.00 | 24.00 | 14.00 | 1.00 | 1.00 |
| Float | - | - | - | 98.00 | - | - | - | - | - | - |
Cashflow (Last 12 Months)
(In Thousands)
| Cashflow (Quarterly) | (In Thousands) | ||||||||||||
| Description | (%) Q/Q | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 |
| Cashflow From Operations | -17.9% | -19,424 | -16,476 | -17,675 | -15,422 | -13,387 | -20,967 | -12,639 | -12,272 | -5,986 | -7,648 | -6,135 | -2,830 |
| Share Based Compensation | -1.0% | 1,922 | 1,941 | 1,837 | 1,348 | 1,359 | 1,361 | 1,228 | 815 | 669 | 348 | 329 | 188 |
| Cashflow From Investing | -13050.2% | -29,588 | -225 | -1,009 | -1,181 | -1,102 | -430 | -609 | -1,614 | -156 | -24.00 | -15.00 | -305 |
| Cashflow From Financing | 104.9% | 26.00 | -534 | 189 | 130 | 217 | -1,420 | 113,414 | -18.00 | - | - | - | - |
PEPG Income Statement
2023-12-31CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) $ in Thousands | 12 Months Ended | |
|---|---|---|
Dec. 31, 2023 | Dec. 31, 2022 | |
| Operating Expenses [Abstract] | ||
| Research and development | $ 68,126 | $ 54,077 |
| General and administrative | 16,640 | 14,224 |
| Total operating expenses | 84,766 | 68,301 |
| Operating loss | (84,766) | (68,301) |
| Other income (expense) | ||
| Interest income | 6,400 | 2,793 |
| Other income (expense), net | (187) | 110 |
| Total other income, net | 6,213 | 2,903 |
| Net loss before income tax | (78,553) | (65,398) |
| Income tax expense | (73) | (3,706) |
| Net loss | $ (78,626) | $ (69,104) |
| Net loss per share, basic | $ (3.3) | $ (4.42) |
| Net loss per share, diluted | $ (3.3) | $ (4.42) |
| Weighted-average common shares outstanding, basic | 23,796,000 | 15,639,728 |
| Weighted-average common shares outstanding, diluted | 23,796,000 | 15,639,728 |
PEPG Balance Sheet
2023-12-31CONSOLIDATED BALANCE SHEETS - USD ($) | Dec. 31, 2023 | Dec. 31, 2022 |
|---|---|---|
| Current assets: | ||
| Cash and cash equivalents | $ 80,774,000 | $ 181,752,000 |
| Marketable Securities | 29,633,000 | 0 |
| Prepaid expenses and other current assets | 2,271,000 | 4,331,000 |
| Total current assets | 112,678,000 | 186,083,000 |
| Property and equipment, net | 4,764,000 | 3,335,000 |
| Operating lease right-of-use asset | 23,620,000 | 26,549,000 |
| Other assets | 1,990,000 | 1,473,000 |
| Total assets | 143,052,000 | 217,440,000 |
| Current liabilities: | ||
| Accounts payable | 1,005,000 | 1,362,000 |
| Accrued expenses | 13,522,000 | 11,913,000 |
| Operating lease liability | 3,004,000 | 5,553,000 |
| Total current liabilities | 17,531,000 | 18,828,000 |
| Operating lease liability, net of current portion | 17,100,000 | 18,981,000 |
| Total liabilities | 34,631,000 | 37,809,000 |
| Stockholders' equity: | ||
| Preferred stock, $0.0001 par value; 10,000,000 shares authorized at December 31, 2023 and 2022, respectively | ||
| Common stock, $0.0001 par value; 500,000,000 shares authorized as of December 31, 2023 and 2022, respectively; 23,823,241 and 23,713,196 shares issued and outstanding as of December 31, 2023 and 2022, respectively | 2,000 | 2,000 |
| Additional paid-in capital | 289,867,000 | 282,566,000 |
| Accumulated other comprehensive income (loss) | 34,000 | (81,000) |
| Accumulated deficit | (181,482,000) | (102,856,000) |
| Total stockholders' equity (deficit) | 108,421,000 | 179,631,000 |
| Total liabilities, convertible preferred stock, and stockholders' equity (deficit) | $ 143,052,000 | $ 217,440,000 |
| Â CEO | Dr. James G. McArthur Ph.D. |
|---|---|
| Â WEBSITE | https://pepgen.com |
| Â INDUSTRY | Biotechnology |
| Â EMPLOYEES | 54 |